Cargando…
Viroimmunotherapy of Thoracic Cancers
Thoracic cancers, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and malignant pleural mesothelioma (MM), cause the highest rate of cancer mortality worldwide. Most of these deaths are as a result of NSCLC; however, prognoses for the other two diseases remain as some of...
Autores principales: | Dash, Alexander S., Patel, Manish R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423488/ https://www.ncbi.nlm.nih.gov/pubmed/28536345 http://dx.doi.org/10.3390/biomedicines5010002 |
Ejemplares similares
-
Viroimmunotherapy for Colorectal Cancer: Clinical Studies
por: Chaurasiya, Shyambabu, et al.
Publicado: (2017) -
Toward comprehensive imaging of oncolytic viroimmunotherapy
por: Chaurasiya, Shyambabu, et al.
Publicado: (2021) -
Systemic cellular viroimmunotherapy for canine high-grade gliomas
por: Cloquell, Ana, et al.
Publicado: (2022) -
Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancer
por: Kim, Sang-In, et al.
Publicado: (2022) -
TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma
por: Hutzen, Brian, et al.
Publicado: (2017)